[Long-term therapy with the respiratory agent fominoben].
D000328:Adult; D000368:Aged; D000813:Anilides / Q000627:therapeutic use; D000996:Antitussive Agents / Q000627:therapeutic use*; D001984:Bronchial Neoplasms / Q000188:drug therapy; D001991:Bronchitis / Q000188:drug therapy; D002908:Chronic Disease; D003371:Cough / Q000188:drug therapy*; D004912:Erythrocytes / Q000187:drug effects; D005260:Female; D006454:Hemoglobins; D006801:Humans; D007962:Leukocytes / Q000187:drug effects; D008297:Male; D008744:Methylamines / Q000627:therapeutic use; D008875:Middle Aged; D009025:Morpholines / Q000627:therapeutic use*; D010998:Pleurisy / Q000188:drug therapy; D011009:Pneumoconiosis / Q000188:drug therapy; D011014:Pneumonia / Q000188:drug therapy; D013183:Sputum; D013997:Time Factors
D000813:Anilides; D000996:Antitussive Agents; D006454:Hemoglobins; D008744:Methylamines; D009025:Morpholines
Langzeittherapie mit dem Atemtherapeutikum Fominoben.